Grupo para la caracterización molecular de las neoplasias hematológicas
Institute of Haematology and Blood Transfusion
Praga, República ChecaPublications en collaboration avec des chercheurs de Institute of Haematology and Blood Transfusion (1)
2018
-
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
The Lancet Oncology, Vol. 19, Núm. 6, pp. 747-757